STAT News

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.

Por STAT News

1 minuto de lectura
Compartir
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas